|
Parasite density
|
116
| | | | |
|
< Median (2,237.2 parasites/µl)
|
43
|
1
| | | |
|
≥ Median
|
73
|
4.03 (0.86–19.0)
|
0.08
|
5.5 (1.07–28.0)
|
0.04
|
|
Number of SP doses
|
116
| | | | |
|
< 3
|
78
|
1
| | | |
|
≥ 3
|
38
|
0.13 (0.02–1.07)
|
0.06
|
0.25 (0.07–0.92)
|
0.04
|
|
MiP preventive strategy
|
116
| | | | |
|
IPTp-SP
|
56
|
1
| | | |
|
CSST/IPTp-SP
|
60
|
0.92 (0.30–2.83)
|
0.89
| | |
|
Triple dhfr 51/59/108 mutation
|
|
No
|
25
|
1
| | | |
|
Yes
|
58
|
1.64 (0.30–8.95)
|
0.57
| | |
|
AL treatment during pregnancy
|
|
0
|
51
|
1
| | | |
|
≥ 1
|
65
|
0.39 (0.12–1.24)
|
0.10
|
0.25 (0.07–0.89)
|
0.03
|
|
Timing Al treatment to delivery
|
|
No treatment
|
51
|
1
| | | |
|
4 to 28 days
|
20
|
0.51 (0.10–2.64)
|
0.43
| | |
|
29 to 42 days
|
21
|
0.001 (0.001–1.01)
|
0.96
| | |
|
43 to 63 days
|
13
|
0.39 (0.04–3.38)
|
0.39
| | |
|
≥ 64 days
|
11
|
1.04 (0.19–5.64)
|
0.97
| | |
|
Age
|
116
| | | | |
|
< Mean (25.2 years ± 6.4
|
58
|
1
| | | |
|
≥ Median
|
58
|
0.88 (0.28–2.71)
|
0.82
| | |
|
Gravidity
|
116
| | | | |
|
Primi-secundigravidae
|
55
|
1
| | | |
|
Multigravidae
|
61
|
0.64 (0.21–1.98)
|
0.44
| | |
|
Malaria episode
|
116
| | | | |
|
< 2
|
37
|
1
| | | |
|
≥ 2
|
79
|
0.82 (0.25–2.65)
|
0.74
| | |
|
Malaria infection at ANC-1 and at delivery
|
|
No
|
85
|
1
| | | |
|
Yes
|
31
|
1.62 (0.50–5.28)
|
0.42
| | |
|
Haemoglobin level at delivery
|
113
| | | | |
|
≥ Mean 11.5 g/dl ± 1.7
|
55
|
1
| | | |
|
< Mean
|
58
|
0.68 (0.22–2.10)
|
0.50
| | |
|
ITN usage
|
101
| | | | |
|
No
|
34
|
1
| | | |
|
Yes
|
67
|
0.46 (0.13–1.55)
|
0.21
| | |
